title: Pregnancy outcome of two patients treated with imatinib.
authors.forename: K
authors.initials: K
authors.lastname: Prabhash
authors.forename: P S R K
authors.initials: PS
authors.lastname: Sastry
authors.forename: G
authors.initials: G
authors.lastname: Biswas
authors.forename: A
authors.initials: A
authors.lastname: Bakshi
authors.forename: N
authors.initials: N
authors.lastname: Prasad
authors.forename: H
authors.initials: H
authors.lastname: Menon
authors.forename: P M
authors.initials: PM
authors.lastname: Parikh
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D007231:Infant, Newborn; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate